Mumbai, India

Aditi Milind Panandikar

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014-2019

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Aditi Milind Panandikar: Innovator in Pharmaceutical Processes

Introduction

Aditi Milind Panandikar is a prominent inventor based in Mumbai, India. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative processes for drug formulation. With a total of 5 patents to her name, Aditi is recognized for her expertise and dedication to advancing medical science.

Latest Patents

Aditi's latest patents include a novel process for the preparation of sodium glucose transporters 2 (SGLT2) inhibitor compounds. This invention discloses a unique method for synthesizing these important compounds, which play a crucial role in managing diabetes. Another significant patent involves the manufacturing of sterile Brinzolamide ophthalmic suspension. This process focuses on creating a sterile formulation of Brinzolamide, utilizing Dry Heat Sterilization to ensure the safety and efficacy of the ophthalmic product.

Career Highlights

Aditi is currently employed at Indoco Remedies Limited, where she applies her innovative skills to enhance pharmaceutical manufacturing processes. Her work has not only contributed to the company's success but has also positively impacted patient care through improved drug formulations.

Collaborations

Aditi collaborates with talented professionals in her field, including Ranjeet Nair and Mangesh Narayan Rajadhyaksha. These partnerships foster a creative environment that encourages the development of groundbreaking pharmaceutical solutions.

Conclusion

Aditi Milind Panandikar stands out as a leading inventor in the pharmaceutical industry. Her innovative processes and dedication to improving drug formulations highlight her significant contributions to medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…